:IVT mRNA

Lifeng Xu1, Chao Li1, Rui Liao1

  • 1National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing 400038, China.

Molecular pharmaceutics
|November 27, 2024
PubMed
概括

在体外转录 (IVT) 的mRNA疫苗显示出希望,但面临挑战. 优化策略,包括人工智能和先进的传递系统,是释放它们对全球健康的全部治疗潜力的关键.